Literature DB >> 9433334

Use of ECT for the inpatient treatment of recurrent major depression.

M Olfson1, S Marcus, H A Sackeim, J Thompson, H A Pincus.   

Abstract

OBJECTIVE: The authors' goals were to determine the frequency and distribution of ECT for general hospital inpatients with recurrent major depression and to estimate the effects of prompt ECT on the length and cost of inpatient care.
METHOD: Data from the 1993 Healthcare Cost and Utilization Project were analyzed to determine the rate of ECT use for adult inpatients with a principal discharge diagnosis of major depression, recurrent. Associations between prompt initial use of ECT (in the first 5 hospital days) and length and cost of inpatient care were examined before and after control for sociodemographic, diagnostic, and hospital organizational characteristics.
RESULTS: An estimated 9.4% of general hospital adult inpatients with a principal diagnosis of recurrent major depression received ECT in the survey year. A majority (59.2%) of these received their initial ECT session within the first 5 days after hospital admission. In univariate analyses, the likelihood of receiving ECT was greater for older patients, whites, privately insured individuals, and patients who lived in more affluent areas. Patients who received ECT tended to have relatively long and costly admissions. After control for several demographic, diagnostic, and hospital organizational characteristics, prompt ECT (as compared with delayed ECT or none) was associated with significantly shorter and less costly inpatient care.
CONCLUSIONS: The longer stays and higher treatment costs associated with ECT may be a consequence of patient selection. When patient selection is taken into account, prompt administration of ECT is associated with shorter and less costly hospital stays. Nonetheless, economically disadvantaged patients are relatively unlikely to receive this treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9433334     DOI: 10.1176/ajp.155.1.22

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  26 in total

1.  Racial differences in the availability and use of electroconvulsive therapy for recurrent major depression.

Authors:  Brady G Case; David N Bertollo; Eugene M Laska; Carole E Siegel; Joseph A Wanderling; Mark Olfson
Journal:  J Affect Disord       Date:  2011-12-12       Impact factor: 4.839

2.  Secondary data bases and their use in outcomes research: a review of the area resource file and the Healthcare Cost and Utilization Project.

Authors:  A E Best
Journal:  J Med Syst       Date:  1999-06       Impact factor: 4.460

Review 3.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Use of depot antipsychotic medications for medication nonadherence in schizophrenia.

Authors:  Joyce C West; Steven C Marcus; Joshua Wilk; Lisa M Countis; Darrel A Regier; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-12-18       Impact factor: 9.306

Review 5.  Depression among older adults with diabetes mellitus.

Authors:  Mijung Park; Charles F Reynolds
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

6.  Contemporary use and practice of electroconvulsive therapy worldwide.

Authors:  Kari Ann Leiknes; Lindy Jarosh-von Schweder; Bjørg Høie
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

7.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

8.  [Electroconvulsive therapy at the Department of Psychiatry and Psychotherapy, University of Munich. Development during the years 1995-2002].

Authors:  T C Baghai; A Marcuse; H-J Möller; R Rupprecht
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

9.  Outcome of electroconvulsive therapy by race in the Consortium for Research on Electroconvulsive Therapy multisite study.

Authors:  Mark D Williams; Teresa Rummans; Shirlene Sampson; Rebecca Knapp; Martina Mueller; Mustafa M Husain; Max Fink; Keith Rasmussen; Kevin O'Connor; Glenn Smith; George Petrides; Charles H Kellner
Journal:  J ECT       Date:  2008-06       Impact factor: 3.635

10.  The efficacy of acute electroconvulsive therapy in atypical depression.

Authors:  Mustafa M Husain; Shawn M McClintock; A John Rush; Rebecca G Knapp; Max Fink; Teresa A Rummans; Keith Rasmussen; Cynthia Claassen; Georgios Petrides; Melanie M Biggs; Martina Mueller; Shirlene Sampson; Samuel H Bailine; Sarah H Lisanby; Charles H Kellner
Journal:  J Clin Psychiatry       Date:  2008-03       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.